Copper deficiency caused by excessive alcohol consumption. 2017

Shunichi Shibazaki, and Shuhei Uchiyama, and Katsuji Tsuda, and Norihide Taniuchi
Department of Emergency and General Internal Medicine, Hitachinaka General Hospital, Hitachinaka, Ibaraki, Japan.

Copper deficiency is a disease that causes cytopaenia and neuropathy and can be treated by copper supplementation. Long-term tube feeding, long-term total parenteral nutrition, intestinal resection and ingestion of zinc are known copper deficiency risk factors; however, alcohol abuse is not. In this case, a 71-year-old man had difficulty waking. He had a history of drinking more than five glasses of spirits daily. He was well until 3 months ago. A month before his visit to our hospital, he could not eat meals but continued drinking. He had macrocytic anaemia on admission. Copper and ceruloplasmin levels were markedly low, and we diagnosed copper deficiency. There were no other known risk factors for copper deficiency. After he began drinking cocoa as a copper supplement, the anaemia ameliorated and he was able to walk. This is the first report showing alcohol abuse as a risk factor for copper deficiency.

UI MeSH Term Description Entries
D008297 Male Males
D002099 Cacao A tree of the family MALVACEAE, order MALVALES, whose seeds are processed to yield cocoa and CHOCOLATE. Cocoa Plant,Theobroma,Theobroma cacao,Plant, Cocoa
D002570 Ceruloplasmin A multi-copper blood FERROXIDASE involved in iron and copper homeostasis and inflammation. Caeruloplasmin,Ferroxidase,Ceruloplasmin Ferroxidase,Ceruloplasmin Oxidase,Ferroxidase I,alpha(2)-Ceruloplasmin,Ferroxidase, Ceruloplasmin,Oxidase, Ceruloplasmin
D003300 Copper A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. Copper-63,Copper 63
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol
D000748 Anemia, Macrocytic Anemia characterized by larger than normal erythrocytes, increased mean corpuscular volume (MCV) and increased mean corpuscular hemoglobin (MCH). Anemias, Macrocytic,Macrocytic Anemia,Macrocytic Anemias
D001068 Feeding and Eating Disorders A group of disorders characterized by physiological and psychological disturbances in appetite or food intake. Appetite Disorders,Eating Disorders,Eating and Feeding Disorders,Feeding Disorders,Appetite Disorder,Disorder, Eating,Disorder, Feeding,Disorders, Eating,Disorders, Feeding,Eating Disorder,Feeding Disorder
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Shunichi Shibazaki, and Shuhei Uchiyama, and Katsuji Tsuda, and Norihide Taniuchi
June 1990, Metabolism: clinical and experimental,
Shunichi Shibazaki, and Shuhei Uchiyama, and Katsuji Tsuda, and Norihide Taniuchi
October 2016, Rinsho shinkeigaku = Clinical neurology,
Shunichi Shibazaki, and Shuhei Uchiyama, and Katsuji Tsuda, and Norihide Taniuchi
January 1982, Duodecim; laaketieteellinen aikakauskirja,
Shunichi Shibazaki, and Shuhei Uchiyama, and Katsuji Tsuda, and Norihide Taniuchi
March 2010, The Netherlands journal of medicine,
Shunichi Shibazaki, and Shuhei Uchiyama, and Katsuji Tsuda, and Norihide Taniuchi
January 1996, Duodecim; laaketieteellinen aikakauskirja,
Shunichi Shibazaki, and Shuhei Uchiyama, and Katsuji Tsuda, and Norihide Taniuchi
March 1999, The Journal of pediatrics,
Shunichi Shibazaki, and Shuhei Uchiyama, and Katsuji Tsuda, and Norihide Taniuchi
January 1994, Medicina clinica,
Shunichi Shibazaki, and Shuhei Uchiyama, and Katsuji Tsuda, and Norihide Taniuchi
April 2021, Cureus,
Shunichi Shibazaki, and Shuhei Uchiyama, and Katsuji Tsuda, and Norihide Taniuchi
April 2014, Clinica chimica acta; international journal of clinical chemistry,
Shunichi Shibazaki, and Shuhei Uchiyama, and Katsuji Tsuda, and Norihide Taniuchi
January 1993, Scandinavian journal of clinical and laboratory investigation. Supplementum,
Copied contents to your clipboard!